A Study of SDI-118 in Participants in Remission From Depression
Condition(s):Depression in RemissionLast Updated:April 22, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Depression in RemissionLast Updated:April 22, 2022Withdrawn
Condition(s):Newly Diagnosed Type 2 Diabetes; Simplified Short-term Intensive Insulin Therapy; Glycemic RemissionLast Updated:June 4, 2019Unknown status
Condition(s):Adult Acute Myeloid LeukemiaLast Updated:October 18, 2023Not yet recruiting
Condition(s):Lupus NephritisLast Updated:October 31, 2019Completed
Condition(s):Acute Myeloid Leukemia (AML) in RemissionLast Updated:August 19, 2022Recruiting
Condition(s):Crohn’s DiseaseLast Updated:September 7, 2017Terminated
Condition(s):Newly Diagnosed Type 2 DiabetesLast Updated:July 20, 2023Active, not recruiting
Condition(s):Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveLast Updated:February 29, 2024Recruiting
Condition(s):Chronic Phase Chronic Myelogenous LeukemiaLast Updated:January 5, 2023Recruiting
Condition(s):Arthritis, RheumatoidLast Updated:April 29, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.